VIVUS, Inc.
Pharmaceutical & medical device company payment data from CMS Open Payments.
Total Payments
$13.6M
Doctors Paid
8,220
Transactions
24,079
2024 Total
$245,506
Payment Breakdown by Category
Research$9.5M (69.5%)
Royalty/License$3.0M (22.4%)
Consulting$487,593 (3.6%)
Food & Beverage$418,589 (3.1%)
Travel$43,998 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $9.5M | 1,239 | 69.5% |
| Royalty or License | $3.0M | 29 | 22.4% |
| Consulting Fee | $487,593 | 107 | 3.6% |
| Food and Beverage | $418,589 | 22,545 | 3.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $110,680 | 64 | 0.8% |
| Travel and Lodging | $43,998 | 71 | 0.3% |
| Charitable Contribution | $39,000 | 15 | 0.3% |
| Space rental or facility fees (teaching hospital only) | $12,050 | 6 | 0.1% |
| Education | $24.78 | 3 | 0.0% |
Payments by Type
Research
$9.5M
1,239 transactions
General
$4.2M
22,840 transactions
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| A Study of VI-0521 on Ambulatory Blood Pressure in Overweight or Obese Subject | $4.4M | 0 | 292 |
| A Phase IV Safety and Efficacy of VI-0521 in Obese Adolescents | $4.2M | 0 | 385 |
| IIT - Anti Obesity Pharmacotherapy vs Patients Using a Wearable Activity Tracker | $535,331 | 0 | 11 |
| IIT - Pancreaze Enzyme Replenishment Therapy | $262,040 | 0 | 6 |
| Long-term Study in US Cystic Fibrosis | $76,406 | 0 | 270 |
| Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms | $40,248 | 0 | 275 |
Payments by Medical Specialty
Top Paid Doctors — Page 3
| Doctor | Specialty | Location | Total | 2024 |
|---|---|---|---|---|
| Israel Crespo, M D, M D | Internal Medicine | Tampa, FL | $771.88 | $0 |
| Dr. Richard Dumois, Md, MD | Gastroenterology | Orlando, FL | $707.38 | $0 |
| Dr. Debra Greenfield, M.d, M.D | Internal Medicine | West Hempstead, NY | $638.46 | $0 |
| Victoria Rothwell, Md, MD | Gastroenterology | Charlotte, NC | $625.08 | $0 |
| Dr. Theofanis Mitsinikos, D.o, D.O | Endocrinology, Diabetes & Metabolism | Stony Brook, NY | $605.67 | $0 |
| Dr. Jose De Leon, M. D, M. D | Obstetrics & Gynecology | Dallas, TX | $588.13 | $0 |
| Dr. Helene Koch, D.o, D.O | Obstetrics & Gynecology | Bala Cynwyd, PA | $584.79 | $0 |
| Dr. Maha Zikra, M.d, M.D | Endocrinology, Diabetes & Metabolism | Orlando, FL | $555.72 | $0 |
| Dr. Jie He, M.d, M.D | Endocrinology, Diabetes & Metabolism | Rockville, MD | $554.10 | $0 |
| Stephen Deal, M.d, M.D | Gastroenterology | Charlotte, NC | $553.21 | $0 |
| Dr. Mark Clayman, Md, MD | Plastic Surgery | Gainesville, FL | $548.23 | $0 |
| Alla Khalfin, D.o, D.O | Endocrinology, Diabetes & Metabolism | Syosset, NY | $547.13 | $0 |
| Unknown Provider | — | — | $544.47 | $0 |
| Dr. Prateek Chapalamadugu, M.d, M.D | Gastroenterology | New Brunswick, NJ | $535.86 | $0 |
| Shivinder Narwal, Md, MD | Pediatric Gastroenterology | Tampa, FL | $533.29 | $0 |
| Dr. Andre Giannakopoulos, M.d, M.D | Internal Medicine | East Meadow, NY | $517.07 | $0 |
| Kristine Trout, Arnp, ARNP | Nurse Practitioner | Clermont, FL | $502.31 | $0 |
| Po Cheng Chu, Md, MD | Specialist | Brooklyn, NY | $489.21 | $0 |
| David Wynne, M.d, M.D | Internal Medicine | Birmingham, AL | $481.94 | $0 |
| Dr. Roland Shepard, Md, MD | Gastroenterology | Tampa, FL | $474.04 | $0 |
| Gowri Balachandar, M.d, M.D | Gastroenterology | Plano, TX | $470.19 | $0 |
| Geovanna Deese, Fnp, FNP | Nurse Practitioner | Charlotte, NC | $468.85 | $0 |
| Dr. Daryl Perlman, D.o, D.O | Internal Medicine | Bethpage, NY | $468.33 | $0 |
| Dr. Chun Wong, M.d, M.D | Internal Medicine | New York, NY | $450.85 | $0 |
| Timothy Huggins, M.d, M.D | Gastroenterology | Weatherford, TX | $443.30 | $0 |
About VIVUS, Inc.
VIVUS, Inc. has made $13.6M in payments to 8,220 healthcare providers, recorded across 24,079 transactions in the CMS Open Payments database. In 2024, the company paid $245,506. The top product by payment volume is QSYMIA ($13.0M).
Payments were distributed across 128 medical specialties. The top specialty by payment amount is Cardiovascular Disease ($281,620 to 52 doctors).
Payment categories include: Food & Beverage ($418,589), Consulting ($487,593), Research ($9.5M), Travel & Lodging ($43,998), Royalties ($3.0M).
VIVUS, Inc. is associated with 4 products in the CMS Open Payments database, including QSYMIA, PANCREAZE, and Qsymia.